Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 43-52 , January 2009

Balancing Risk and Reward in Target Delineation for Highly Conformal Radiotherapy in Head and Neck Cancer

  • Avraham Eisbruch, MD

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • Corresponding Author InformationAddress reprint requests to Avraham Eisbruch, MD, Department of Radiation Oncology, University of Michigan Hospital, Ann Arbor, MI 48109-0010
    • ,
  • Vincent Gregoire, MD, PhD, FRCR

      Affiliations

    • Radiation Oncology Department and Center for Molecular Imaging and Experimental Radiotherapy, Université catholique de Louvain, St-Luc University Hospital, Brussels, Belgium

References 

  1. Hong TS, Chappell RJ, Harari PM. Variations in target delineation for head and neck IMRT: An international multi-institutional study. Int J Radiat Oncol Biol Phys. 2004;60:S157
  2. Som PM. The present controversy over the imaging method of choice for evaluating the soft tissues of the neck. AJNR Am J Neuroradiol. 1997;18:1869–1872
  3. Ahn PH, Garg MK. Positron emission tomography/computed tomography for target delineation in head and neck cancers. Semin Nucl Med. 2008;38:141–148
  4. Rasch C, Eisbruch A, Reimeijer P, et al. Irradiation of paranasal sinus tumors, a delineation and dose comparison study. Int J Radiat Oncol Biol Phys. 2002;52:120–127
  5. Chao KS, Bhide S, Chen H, et al. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phy. 2007;68:1512–1521
  6. Jeanneret-Sozzi W, Moeckli R, Valley JF, et al. The reasons for discrepancies in target volume delineation: A SASRO study on head-and-neck and prostate cancers. Strahlenther Onkol. 2006;182:450–457
  7. Steenbakkers RDJ, Fitton I, Deurloo K, et al. Observer variation in delineation of nasopharyngeal carcinoma for radiotherapy: A 3-D analysis. Int J Radiat Oncol Biol Phys. 2004;60:S160
  8. Geets X, Daisne JF, Arcangeli S, et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: Comparison between CT-scan and MRI. Radiother Oncol. 2005;77:25–31
  9. Ashamalla H, Rafla S, Parikh K, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:1016–1023
  10. Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with integrated CT/PET. Int J Radiat Oncol Biol Phys. 2003;57:853–863
  11. Syed R, Bomanji JB, Nagabhushan N, et al. Impact of combined FDG PET/CT in head and neck tumors. Br J Cancer. 2005;92:1046–1050
  12. Daisne JF, Duprez T, Weynand B, et al. Accuracy of CT scan (MRI and FDG-PET in delineating the tumor volume in pharyngo-laryngeal squamous cell carcinomas treated by radiotherapy: Validation with the macroscopic tumor specimen used as reference). Radiology. 2004;233:93–100
  13. Geets X, Daisne JF, Tomsej M, et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies. Radiother Oncol. 2006;78:291–297
  14. Paulino AC, Koshy M, Howell R, et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:1385–1392
  15. Schwartz DL, Ford EC, Rajendran J, et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck. 2005;27:478–487
  16. Schingal DA, Vogel WV, Hoffmann AL, et al. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:1282–1289
  17. Gregoire V, Daisne JF, Geets X. Comparison of CT- and FDG-PET-defined GTV. Int J Radiat Oncol Biol Phys. 2005;63:308–309
  18. Geets X, Lee J, Bol A, et al. A gradient-based method for segmenting FDG-PET images: Methodology and validation. Eur J Nucl Med Mol Imaging. 2007;34:1427–1438
  19. Grégoire V, Daisne JF, Geets X, et al. Selection and delineation of target volumes in head and neck tumors. Rays. 2003;28:217–224
  20. Soto D, Piert M, Eisbruch A. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy of head and neck cancer. Radiother Oncol. 2008;Jun 12; [Epub ahead of print]
  21. Scarfone C, Lavely WC, Cmelak AJ, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med. 2004;45:543–552
  22. Wang D, Schultz CJ, Jursinic PA, et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:143–151
  23. Madani I, vanderstraeten B, Bral S, et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:126–135
  24. Vineberg KA, Eisbruch A, Coselmon MM, et al. Is uniform target dose possible in IMRT plans in the head and neck?. Int J Radiat Oncol Biol Phys. 2002;52:1159–1172
  25. Tome WA, Fowler JF. Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys. 2000;48:593–599
  26. Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys. 2000;47:551–560
  27. Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol. 2005;6:112–117
  28. Geets X, Tomsej M, Lee JA, et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: Impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol. 2007;85:105–115
  29. Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck. 2002;24:127–135
  30. Chao KS, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2001;49:1171–1182
  31. Lee NY, Mechalakos JG, Nehmeh S, et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: A feasibility study. Int J Radiat Oncol Biol Phys. 2008;70:2–13
  32. Alber M, Paulsen F, Eschmann SM, et al. On biologically conformal boost dose optimization. Phys Med Biol. 2003;48:N31–N35
  33. Grosu AL, Souvatzoglou M, Rpoer B, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:541–551
  34. Nehmeh SA, Lee NY, Schroder H, et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70:235–242
  35. Thorwarth D, Eschmann SM, Holzner F, et al. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol Biol Phys. 2007;68:515–521
  36. O'Sullivan B, Warde P, Grice B, et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 2001;51:332–343
  37. Lin CY, Lee LY, Huang SF. Treatment outcome of combined modalities for buccal cancers: Unilateral or bilateral neck radiation?. Int J Radiat Oncol Biol Phys. 2007;68:750–757
  38. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117–1126
  39. Chao KS, Wippold FJ, Ozygit G, et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys. 2002;53:1174–1184
  40. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49–60
  41. Eisbruch A, Marsh L, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28–42
  42. Yao M, Chang K, Funk GF, et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of Iowa experience. Int J Radiat Oncol Biol Phys. 2007;67:1332–1341
  43. Gregoire V, Coche E, Cosnard G, et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy (Proposal for standardizing terminology and procedure based on the surgical experience). Radiother Oncol. 2000;56:135–150
  44. Eisbruch A, Foote RL, O'Sullivan B, et al. Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol. 2002;12:238–249
  45. Grégoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA (EORTC, GORTEC, NCIC, RTOG consensus guidelines). Radiother Oncol. 2003;69:227–236
  46. Grégoire V, Eisbruch A, Hamoir M, et al. Proposal for the delineation of the nodal CTV in the node positive and the post-operative neck. Radiother Oncol. 2006;79:15–20
  47. Som PM, Curtin HD, Mancuso AA. An image-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classification. Arch Otolaryngol Head Neck Surg. 1999;125:388–396
  48. Rouviere H. Lymphatic Systems of the Head and Neck. Ann Arbor, MI: Edwards Brothers; 1938;
  49. Murdoch-Kinch MA, Kim HM, Vineberg K, et al. Dose-response relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Rad Onc Biol Phys. 2008;72:373–382
  50. Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70:660–665
  51. Proctor B. Embryology and anatomy of the eustachian tube. Arch Otolaryngol. 1967;86:503–514
  52. Ng SH, Chang JT, Chan SC, et al. Nodal metastases of nasopharyngeal carcinoma: Patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1073–1080
  53. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration following chemo-irradiation of head and neck cancer: Which anatomical structures are affected, and can they bespared by IMRT?. Int J Rad Onc Biol Phys. 2004;60:1425–1439
  54. Feng F, Kim HM, Lyden T, et al. IMRT of head and neck cancer aiming at reducing dysphagia: Early dose-volume-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007;68:1289–1298
  55. Fisch U. Cervical lymph flow following surgery in the neck. In:  Fisch U editors. Lymphography of the Cervical Lymphatic System. Philadelphia: WB Saunders; 1968;p. 112–141
  56. Amdur RJ, Li JG, Hinerman RW, et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck. 2004;26:257–263
  57. Dabaja BS, Suki D, Bonnen M, et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: Comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys. 2005;63:1000–1005
  58. Lee N, Mechalakos J, Puri DR, et al. Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2007;68:1299–1309
  59. Thorstad W, Nussenbaum B, Adkins DR, et al. Recurrences in the low neck after IMRT of head and neck cancer (ASTRO 2008). Int J Radiat Oncol Biol Phys. 2008;72(Suppl 1):S387;(Abstr. 2488), 2008
  60. Khuntia D, Harris J, Bentzen SM, et al. Comparisons of mucositis between IMRT and conventional RT in an RTOG study of post-operative chemotherapy or cetuximab-chemotherapy (ASTRO 2008). Int J Radiat Oncol Biol Phys. 2008;72(Suppl 1):S33;(Abstr. 70)
  61. Eisbruch A. Reducing xerostomia by IMRT: What can, and cannot, be achieved. J Clin Oncol. 2007;25:4863–4864
  62. Lee N, Chuang C, Quivey JM, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:630–637
  63. Sanguineti G, Endres EJ, Gunn BG, et al. Is there a “mucosa-sparing” benefit of IMRT for head-and-neck cancer?. Int J Radiat Oncol Biol Phys. 2006;66:931–938
  64. Fua TF, Corry J, Milner AD, et al. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: Clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys. 2007;67:976–981
  65. Koom WS, Kim TH, Shin KH, et al. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas. Head Neck. 2008;30:159–169
  66. Guerrero Urbano T, Clark CH, Hansen VN, et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol. 2007;85:36–41
  67. Lauve A, Morris M, Schmidt-Ullrich R, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—Clinical results. Int J Radiat Oncol Biol Phys. 2004;60:374–387
  68. Mazeron JJ, Simon JM, Le Péchoux C, et al. Effect of dose rate on local control and complications in irradiation of T1-2 carcinomas of tongue and floor of mouth with interstitial iridium-192. Radiother Oncol. 1991;21:39–47
  69. Lee I, Eisbruch A. The dose-equivalent increase of mucositis by adding concurrent chemotherapy to irradiation of head and neck cancer (ASTRO 2008). Int J Radiat Oncol Biol Phys. 2008;72(Suppl 1):S157;(Abstr. 1098)
  70. Amosson CM, The BS, Garg AK, et al. Accelerated fractionation for head and neck cancer using the SMART boost technique. Int J Radiat Oncol Biol Phys. 2003;57:S306;(abstr 1076)
  71. Posner MR, Hershok DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–1715
  72. Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695–1704
  73. Posner M. Evolving strategies for combined modality therapy for locally advanced head and neck cancer. Oncologist. 2007;12:967–974
  74. Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol. 1989;16:83–101
  75. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radio resistance. Nat Rev Cancer. 2008;8:545–554
  76. Eisbruch A. Commentary: Induction chemotherapy for head and neck cancer: Hypothesis-based rather than evidence-based medicine. Oncologist. 2007;12:975–977
  77. Woodford C, Yartsev S, Dar AR, et al. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys. 2007;69:1316–1322
  78. Klug C, Keszthelyi D, Ploder O, et al. Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: Evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients. Head Neck. 2004;26:224–231
  79. Konski AA, Cheng JD, Goldberg M, et al. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2007;69:358–363

PII: S1053-4296(08)00063-5

doi: 10.1016/j.semradonc.2008.09.008

Seminars in Radiation Oncology
Volume 19, Issue 1 , Pages 43-52 , January 2009

Article Tools

* Image Usage & Resolution